Literature DB >> 31748757

Expression of CDX2 in metastatic prostate cancer.

C Guerrieri1, Z Jobbagy1, R Hudacko2.   

Abstract

Entities:  

Keywords:  CDX2; Immunohistochemistry; Prostate adenocarcinoma

Mesh：

Substances：

Year:  2019        PMID： 31748757      PMCID： PMC8138494          DOI： 10.32074/1591-951X-19-19

Source DB:  PubMed          Journal:  Pathologica        ISSN： 0031-2983


× No keyword cloud information.
  5 in total

1.  CDX2 as a marker for intestinal differentiation: Its utility and limitations.

Authors:  Reda S Saad; Zeina Ghorab; Mahmoud A Khalifa; Mei Xu
Journal:  World J Gastrointest Surg       Date:  2011-11-27

2.  Expression of CDX2 in benign tissue and adenocarcinoma of the prostate.

Authors:  Mehsati Herawi; Angelo M De Marzo; Glen Kristiansen; Jonathan I Epstein
Journal:  Hum Pathol       Date:  2006-08-10       Impact factor: 3.466

3.  Prostate adenocarcinoma with a rectal metastasis.

Authors:  Nwabundo Nwankwo; Aibek E Mirrakhimov; Teresita Zdunek; Nora Bucher
Journal:  BMJ Case Rep       Date:  2013-04-30

4.  Cdx2, cytokeratin 20, thyroid transcription factor 1, and prostate-specific antigen expression in unusual subtypes of prostate cancer.

Authors:  Katia Ramos Moreira Leite; Cristina A T S Mitteldorf; Miguel Srougi; Marcos F Dall'oglio; Alberto A Antunes; José Pontes; Luiz Heraldo Camara-Lopes
Journal:  Ann Diagn Pathol       Date:  2008-04-18       Impact factor: 2.090

5.  Distinguishing prostatic from colorectal adenocarcinoma on biopsy samples: the role of morphology and immunohistochemistry.

Authors:  Christopher L Owens; Jonathan I Epstein; George J Netto
Journal:  Arch Pathol Lab Med       Date:  2007-04       Impact factor: 5.534
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.